$PURE 8-K SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities This Securities Purchase Agreement (this “Agreement”) is dated as of October 15, 2026, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its ...
15 Jun 2026	8-K: Results of Operations and Financial Condition
05 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
17 Mar 2026	8-K: Results of Operations and Financial Condition
20 Feb 2026	8-K: Submission of Matters to a Vote of Security Holders
15 Dec 2025	8-K: Results of Operations and Financial Condition
19 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
29 Oct 2025	8-K: Results of Operations and Financial Condition
16 Jun 2025	8-K: Results of Operations and Financial Condition
17 Mar 2025	8-K: Results of Operations and Financial Condition
28 Jan 2025	8-K: Submission of Matters to a Vote of Security Holders
16 Dec 2024	8-K: Results of Operations and Financial Condition
29 Oct 2024	8-K: Results of Operations and Financial Condition
20 Sep 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
09 Aug 2024	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
14 Jun 2024	8-K: Results of Operations and Financial Condition
07 May 2024	8-K: Departure/Election of Directors or Officers; Compensation
27 Mar 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
18 Mar 2024	8-K: Results of Operations and Financial Condition
26 Feb 2024	8-K: Submission of Matters to a Vote of Security Holders

Comments